ProPhase Labs
On 11 August 2021, ProPhase Labs, a diversified medical science and technology company, announced the acquisition of Nebula Genomics by its recently formed subsidiary, ProPhase Precision Medicine, Inc., for about $14.6 million in a combination of ProPhase Labs common stock and cash.Nebula Genomics is accredited by the Better Business Bureau and boasts an A rating on the BBB website. There are only six customer reviews, and they're all 1-star, with most comments being about extended results wait times past the suggested 12-14 week period.Our offices are located in San Francisco and Boston, two global centers of tech and biotech innovation. What does Nebula Genomics offer consumers We offer the most affordable Whole Genome Sequencing on the market.
What lab does nebula use : Oasis Labs
Take Control of your Genomic Data. Nebula Genomics has partnered with Oasis Labs to give you more control over your data and provide maximum security.
Who is the CEO of Nebula Genomics
Kamal Obbad is the Chief Executive Officer of Nebula Genomics.
Is Nebula owned by curiosity stream : Who owns Nebula Nebula is owned and operated by Standard and the creators, with Curiosity Inc (CuriosityStream) holding a minority stake.
Nebula Genomics is the leading privacy-focused personal genomics service. Our mission is to make direct-to-consumer DNA testing secure.
the US
majority of publicly traded and privately held genomics firms in our database were in the US; 75% and 62%, re- spectively. Canada, Germany, France, United Kingdom, and Japan rounded out the top six countries (see Table 1).
Is Nebula Genomics free
Nebula Genomics offers free DNA uploads, free DNA expansion, and free DNA analysis. Users can upload SNP data from 23andMe or AncestryDNA and receive enhanced information about their genome.1. 30x Whole Genome Sequencing. This is a sequencing method that provides a comprehensive analysis of your genetic makeup and covers both coding and non-coding regions. It uses Illumina technology and sequences a small saliva sample to provide high-depth coverage and accurate results.Nebula Genomics offers a 30x Whole-Genome Sequencing service that decodes 100% of your DNA. In contrast, Invitae and other clinical laboratory-based genetic tests cost hundreds of dollars to test a single gene.
Masood Khan – Founder Director – Nebula Companies | LinkedIn.
Who is Curiosity Stream ownership : Shareholders
| Name | Equities | % |
|---|---|---|
| Hendricks Factual Media LLC 39.43 % | 20,928,438 | 39.43 % |
| Jonathan Huberman 3.093 % | 1,641,637 | 3.093 % |
| Vanguard Global Advisers LLC 2.689 % | 1,427,358 | 2.689 % |
| Parallax Volatility Advisers LP 1.204 % | 639,017 | 1.204 % |
What happened between Curiosity Stream and Nebula : Nebula became unbundled from Curiosity Stream's plans beginning 2024, though one year of access would still be provided to subscribers that renewed by the end of 2023. Before a price increase in 2022, the service was offered at $19.99 per year for the standard annual subscription.
Does Nebula Genomics sell your data
If you chose to participate in scientific research, we may also disclose your Genetic Data to those third parties that we partner with to conduct such research. We will never disclose your Genetic Data for research purposes without you first choosing to participate in such research.
Top 20 Genomics Companies in the World
- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
- CRISPR Therapeutics AG (NASDAQ:CRSP)
- Krystal Biotech, Inc.
- Blueprint Medicines Corporation (NASDAQ:BPMC)
- Intellia Therapeutics, Inc.
- Pacific Biosciences of California, Inc.
- Genus plc (LON:GNS.
- Beam Therapeutics Inc.
Illumina
Illumina is the leading provider of sequencing services and sells both instruments and reagents for genome sequencing. Illumina was founded in 1998 and now controls over 80% of the sequencing market. The company reported a 2021 revenue of $4.526 billion and a market cap of $28.92 billion as of September.
Does nebula sell your DNA : On the Nebula platform, people can opt to get sequenced and not sell their genetic data. But if they do choose to share their genomes, they'll be connected directly to interested researchers, biotech and pharmaceutical companies.